Closed · W81XWH-20-ALSRP-CDA · CFDA 12.420 · Discretionary
DoD Amyotrophic Lateral Sclerosis Clinical Development Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- July 30, 2020
- Close date
- 3
- Expected awards
The verdict
DoD Amyotrophic Lateral Sclerosis Clinical Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 3
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Amyotrophic Lateral Sclerosis Clinical De… is closed (last close July 30, 2020). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed July 30, 2020
Est. Total Funding
$1,440,000
Expected Awards
3
Instrument
Grant
Description
The intent of the FY20 ALSRP Clinical Development Award mechanism is to support studies leveraging human-based ALS resources to enrich clinical trials, in addition to projects designed to optimize components of current ALS clinical care. Leveraging can refer to the use of existing well-characterized and highly curated resources, or collaboration with ongoing clinical research to amplify potential gains in knowledge. Analysis of results and/or biosamples collected under these projects should be made broadly available through deposition in existing publicly available curated repositories and data platforms.Examples of human-based resources include ongoing or completed clinical trial datasets, biorepositories of clinical specimens, large transcriptome/proteome/metabolomic datasets, and databases of clinical data and/or metadata. The applicant must demonstrate availability of, and accessibility to, the necessary resources to accomplish the proposed aims. The resources must be available at the time of application submission. Collection of specimens and/or data at additional time points from participants in an existing cohort is allowed. Applications are encouraged to include diversity in their sample populations.A list of suitable resources can be found on the ALSRP web page (https://cdmrp.army.mil/alsrp/default). Other resources may be used, provided a letter of support adequately describes the relevant repository parameters and mechanisms for broad access to data and samples.Examples of studies appropriate for submission to the Clinical Development Award include, but are not limited to:• Using human subject-based resources to better define subtypes, predict therapeutic response, or assess prognosis• Correlating clinical trial-related biosamples, imaging, or epidemiological data with clinical outcomes• Adding a companion aim/goal to an anticipated/ongoing clinical trial, not otherwise supported by the trial• Studies to evaluate optimizing components of current established ALS multidisciplinary clinical care such as respiratory care strategies, use of approved devices, or specific symptom management strategies
Catch-all / unrestricted eligibility mark · W81XWH-20-ALSRP-CDA
Grants.gov marks DoD Amyotrophic Lateral Sclerosis Clinical De… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Amyotrophic Lateral Sclerosis Clinical De… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |